Table 3.
Association between MMP-9 expression and clinic-pathological parameters
| MMP-9 | Score 0 | Score 1 | Score 2 | Score 3 | p |
|---|---|---|---|---|---|
| Age (years) | |||||
| Mean ± SD | 47.73±15.51 | 47.75±11.68 | 48.36±12.49 | 53.29±7.27 | 0.801 |
| Gender (%) | |||||
| Male | 14 (46.67%) | 7 (23.33%) | 4 (13.33%) | 5 (16.67%) | 0.496 |
| Female | 16 (53.33%) | 5 (16.67%) | 7 (23.33%) | 2 (6.67%) | |
| Sites (%) | |||||
| Tongue | 13 (54.17%) | 5 (20.83%) | 4 (16.67%) | 2 (8.33%) | 0.105 |
| Buccal and/or labial | 16 (47.06%) | 6 (17.65%) | 7 (20.59%) | 5 (14.71%) | |
| Others | 1 (50%) | 0 | 1 (50%) | 0 | |
| Parameters | |||||
| Oral mucosa (%) | 14 (70%) | 3 (15%) | 3 (15%) | 0 | 0.048 |
| Epithelial hyperplasia (%) | 11 (55%) | 5 (25%) | 2 (10%) | 2 (10%) | |
| Epithelial dysplasia (%) | 5 (25%) | 4 (20%) | 6 (30%) | 5 (25%) |